Aytu Biopharma (AYTU) Intangibles (2015 - 2026)

Aytu Biopharma (AYTU) has 12 years of Intangibles data on file, last reported at $42.5 million in Q1 2026.

• On a quarterly basis, Intangibles fell 40.55% year-over-year to $42.5 million in Q1 2026; TTM through Mar 2026 was $42.5 million, a 40.55% decrease from a year earlier, with the FY2025 full-year figure at $42.2 million, down 19.55% from the prior year.
• Intangibles for Q1 2026 stood at $42.5 million, down from $58.4 million in the prior quarter.
• Over the last five years, Intangibles for AYTU reached as high as $94.2 million in Q2 2022 and fell as low as $41.4 million in Q3 2025.
• Historically, Intangibles has averaged $65.8 million across 5 years, with a median of $59.0 million in 2023.
• Across the five-year window, Intangibles surged 146.45% in 2022 and sank 40.55% in 2026, its largest moves.
• Year by year, Intangibles stood at $89.6 million in 2022, then sank by 37.79% to $55.7 million in 2023, then slipped by 10.33% to $50.0 million in 2024, then rose by 16.9% to $58.4 million in 2025, then declined by 27.24% to $42.5 million in 2026.
• Per Business Quant data, the three most recent Intangibles figures were $42.5 million in Q1 2026, $58.4 million in Q4 2025, and $41.4 million in Q3 2025.